Gene · 3398
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CCND1 Overexpression in Idiopathic Dilated Cardiomyopathy: A Promising Biomarker? | Genes (Basel) | 2023 | 37372424 | PubTator, text mining | PubMed |
| Pluripotent stem cell-derived model of the post-implantation human embryo. | Nature | 2023 | 37369347 | PubTator, text mining | PubMed |
| Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK-dependent colorectal cancer. | Cancer Sci | 2023 | 37357017 | PubTator, text mining | PubMed |
| scTour: a deep learning architecture for robust inference and accurate prediction of cellular dynamics. | Genome Biol | 2023 | 37353848 | PubTator, text mining | PubMed |
| Crosstalk between Noncoding RNAs and the Epigenetics Machinery in Pediatric Tumors and Their Microenvironment. | Cancers (Basel) | 2023 | 37345170 | PubTator, text mining | PubMed |
| Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2/Pim1 axis. | J Neuroinflammation | 2023 | 37344856 | PubTator, text mining | PubMed |
| Cell transplantation therapies for spinal cord injury focusing on bone marrow mesenchymal stem cells: Advances and challenges. | World J Stem Cells | 2023 | 37342219 | PubTator, text mining | PubMed |
| The role of transcription factors in shaping regulatory T cell identity. | Nat Rev Immunol | 2023 | 37336954 | PubTator, text mining | PubMed |
| In Vitro Culture Alters Cell Lineage Composition and Cellular Metabolism of Bovine Blastocyst. | bioRxiv | 2023 | 37333292 | PubTator, text mining | PubMed |
| Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre- and postcapillary pulmonary hypertension. | Pulm Circ | 2023 | 37332851 | PubTator, text mining | PubMed |
| H3K27me3-modulated Hofbauer cell BMP2 signalling enhancement compensates for shallow trophoblast invasion in preeclampsia. | EBioMedicine | 2023 | 37331163 | PubTator, text mining | PubMed |
| Signaling mechanisms in renal compensatory hypertrophy revealed by multi-omics. | Nat Commun | 2023 | 37328470 | PubTator, text mining | PubMed |
| Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis. | Front Oncol | 2023 | 37324026 | PubTator, text mining | PubMed |
| Canonical BAF complex activity shapes the enhancer landscape that licenses CD8+ T cell effector and memory fates. | Immunity | 2023 | 37315534 | PubTator, text mining | PubMed |
| SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses. | Front Cell Dev Biol | 2023 | 37313439 | PubTator, text mining | PubMed |
| MeCP2 dysfunction prevents proper BMP signaling and neural progenitor expansion in brain organoid. | Ann Clin Transl Neurol | 2023 | 37302988 | PubTator, text mining | PubMed |
| Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis. | Nutrients | 2023 | 37299554 | PubTator, text mining | PubMed |
| TCGA RNA-Seq and Tumor-Infiltrating Lymphocyte Imaging Data Reveal Cold Tumor Signatures of Invasive Ductal Carcinomas and Estrogen Receptor-Positive Human Breast Tumors. | Int J Mol Sci | 2023 | 37298307 | PubTator, text mining | PubMed |
| From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions. | Acta Neuropathol | 2023 | 37286732 | PubTator, text mining | PubMed |
| The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer. | Front Immunol | 2023 | 37275913 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3398/papers?page=16